# Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/molecular-biomarkers-of-disease-outcomes-and-mechanisms-of-acquired-resistance/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Noura J. Choudhury,Antonio Marra,Jane Sze Yin Sui,Jessica Flynn,Soo‐Ryum Yang,Christina J. Falcon,Pier Selenica,Adam J. Schoenfeld,Natasha Rekhtman,Daniel R. Gomez,Michael F. Berger,Marc Ladanyi,Maria E. Arcila,Charles M. Rudin,Gregory J. Riely,Mark G. Kris,Glenn Heller,Jorge S. Reis‐Filho,Helena A. Yu |
| Citations | 104 |
| DOI | 10.1016/j.jtho.2022.11.022 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086422019323/pdf |
| OpenAlex ID | https://openalex.org/W4310859551 |
| PMID | 36494075 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Charles M. Rudin](https://scholariq.org/researchers/charles-m-rudin/)
- [Mark G. Kris](https://scholariq.org/researchers/mark-g-kris/)
- [Marc Ladanyi](https://scholariq.org/researchers/marc-ladanyi/)
- [Gregory J. Riely](https://scholariq.org/researchers/gregory-j-riely/)
- [Jorge S. Reis‐Filho](https://scholariq.org/researchers/jorge-s-reis-filho/)

## Paper funders

Showing 8 of 15.

- [LUNGevity Foundation](https://scholariq.org/funders/lungevity-foundation/)
- [Bristol-Myers Squibb](https://scholariq.org/funders/bristol-myers-squibb/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [GlaxoSmithKline](https://scholariq.org/funders/glaxosmithkline/)
- [Sanofi](https://scholariq.org/funders/sanofi/)
- [F. Hoffmann-La Roche](https://scholariq.org/funders/f-hoffmann-la-roche/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.